Clinical trial
A Comparison of Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade in Patients Under Sevoflurane or TIVA Anesthesia.
NCT05037006 is registered in ClinicalTrials.gov with Pontificia Universidade Catolica de Sao Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade in Patients Under Sevoflurane or TIVA Anesthesia.
- Lead sponsor
- Pontificia Universidade Catolica de Sao Paulo
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 1, 2021
- Completion date
- December 20, 2021
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuromuscular blockade, neuromuscular blockade, residual